Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 7.95414 | 93 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 8.04516 | 93 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 7.97355 | 93 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 8.14692 | 93 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 8.03835 | 93 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 7.70772 | 93 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 7.25942 | 91 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 7.84557 | 93 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 7.66736 | 92 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 7.95801 | 93 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 8.01194 | 94 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 7.9424 | 93 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 8.16687 | 94 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 7.95772 | 93 |